dalteparin has been researched along with Elevated ICP (Intracranial Pressure) in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fraint, E | 1 |
| Miller, R | 1 |
| Walter, A | 1 |
| Forbes, JA | 1 |
| Reig, AS | 1 |
| Tomycz, LD | 1 |
| Tulipan, N | 1 |
2 other studies available for dalteparin and Elevated ICP (Intracranial Pressure)
| Article | Year |
|---|---|
Posterior Reversible Encephalopathy Syndrome and Cerebral Sinus Thrombosis in a Case of Pediatric B-Cell ALL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Ischemia; Cerebral Infarction; Child, Preschoo | 2017 |
Intracranial hypertension caused by a depressed skull fracture resulting in superior sagittal sinus thrombosis in a pediatric patient: treatment with ventriculoperitoneal shunt insertion.
Topics: Administration, Oral; Anticoagulants; Cerebral Angiography; Child; Enoxaparin; Follow-Up Studies; He | 2010 |